Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/24/1991 | US5051496 Polypeptides encoded by DNA fragments for detection of AIDS |
09/24/1991 | US5051443 Wound healing agents for eyes a nonsteroid antiinflammatory agent |
09/24/1991 | US5051405 Modified dipeptides and tripeptides as anticoagulants |
09/24/1991 | US5051404 Tripeptide compounds having hypotensive activity |
09/24/1991 | US5051403 Method of treating ischemia-related neuronal damage |
09/24/1991 | US5051402 Fungicides, immunosuppressants and antiphlogistic agents |
09/24/1991 | US5051401 Inhibition of mineral deposition by phosphorylated and related polyanionic peptides |
09/24/1991 | US5051400 Administering oligopeptides as antiemetics |
09/24/1991 | US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems |
09/24/1991 | US5051363 Method for modifying the toxicity of DNA reactive cross-linking agents to cells |
09/24/1991 | US5051353 Preservation and restoration of hemoglobin in blood substitutes |
09/24/1991 | US5051264 Controlling the fibrinolytic system for treatment of myocardial infraction |
09/24/1991 | CA2037151A1 Plasmodium sporozoite antigen |
09/24/1991 | CA1289472C Tpa-containing medical composition |
09/24/1991 | CA1289420C Method of producing high aqueous volume multilamellar vesicles |
09/23/1991 | WO1991014447A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
09/23/1991 | CA2078783A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum |
09/23/1991 | CA2038509A1 Bu-4164e - a and b, prolyl endopeptidase inhibitors |
09/22/1991 | WO1991014436A1 Reagents and methods for modulating gene expression through rna mimicry |
09/22/1991 | CA2078659A1 Reagents and methods for modulating gene expression through rna mimicry |
09/21/1991 | CA2038581A1 Seroreactive epitopes of human papillomavirus (hpv) 16 proteins |
09/21/1991 | CA2038534A1 Hyperimmune globulin against hepatitis c virus and method for making same |
09/20/1991 | CA2038547A1 Lipopeptide compounds |
09/20/1991 | CA2038532A1 Antibiotic agents |
09/20/1991 | CA2038528A1 Lipopeptide derivatives |
09/20/1991 | CA2038525A1 Lipopeptide compounds |
09/20/1991 | CA2038497A1 Lipopeptide derivatives |
09/20/1991 | CA2038495A1 Antibiotic agents |
09/20/1991 | CA2038397A1 Monoclonal antibody reactive with a novel hla determinant on mhc class i molecules and method for activating lymphocytes |
09/19/1991 | WO1991013986A1 PORCINE INTERLEUKIN-1α NUCLEOTIDE SEQUENCES AND POLYPEPTIDES |
09/19/1991 | WO1991013985A1 Leukaemia inhibitory factor |
09/19/1991 | WO1991013982A1 Genetically engineered human lactoferrin |
09/19/1991 | WO1991013981A1 New protein, its manufacture and use |
09/19/1991 | WO1991013911A1 Peptide inhibitor of human immunodeficiency virus infection blocks virus interactions with a novel cellular receptor |
09/19/1991 | WO1991013908A1 Neutrophil stimulating peptides |
09/19/1991 | WO1991013905A1 Virus free platelet derivatives and method of making same |
09/19/1991 | WO1991013631A1 Method for enhancing antibody transport through capillary barriers |
09/19/1991 | WO1991013629A1 Use of lactoferrin to counter the toxic effects of endotoxins |
09/19/1991 | WO1991013628A1 Pharmaceutical compositions |
09/19/1991 | WO1991012270A3 Novel platelet aggregation inhibitors from the leech |
09/19/1991 | WO1991011515A3 Leukocyte-derived growth factor |
09/19/1991 | WO1991011117A3 Dietary supplements comprising vitamins and minerals |
09/19/1991 | WO1991004058A3 Treatment of conditions and disease |
09/19/1991 | DE4008354A1 Neues protein, seine herstellung und verwendung Novel protein, its preparation and use |
09/18/1991 | EP0447353A1 A pharmaceutical preparation for the maturation of prothymocytes |
09/18/1991 | EP0447298A1 Method for coating active agents with PH-sensitive polymers |
09/18/1991 | EP0447188A2 7-Oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseases |
09/18/1991 | EP0447186A1 N-acylated cyclohexapeptide compounds |
09/18/1991 | EP0446931A1 Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology |
09/18/1991 | EP0446876A2 Secretory component-containing composition |
09/18/1991 | EP0446850A2 Process for purifying recombinant human beta-interferon |
09/18/1991 | EP0446797A2 Synthetic peptides containing factor VIIa sequences and their use |
09/18/1991 | EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody |
09/18/1991 | EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity |
09/18/1991 | EP0446699A1 Inhibitors of nitric oxide biosynthesis |
09/18/1991 | EP0446582A1 Method for producing of recombinant human cysteineless gamma-interferon free of methionine at n-terminal |
09/18/1991 | EP0446485A2 Peptide analogues with renininhibiting activity |
09/18/1991 | EP0446361A1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide |
09/18/1991 | EP0446298A1 Fast buccal tablet |
09/18/1991 | EP0446283A1 Synthetic interleukin-6 |
09/18/1991 | EP0446279A1 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
09/18/1991 | EP0446230A1 Treatment of myelosuppression associated with acquired immune deficiency |
09/18/1991 | EP0193608B1 Gif-2 and its preparation |
09/18/1991 | EP0126153B1 Vascular permeability factor |
09/18/1991 | CN1054537A Improved diluent formulation for daptomycin |
09/17/1991 | US5049659 Proteins which induce immunological effector cell activation and chemattraction |
09/17/1991 | US5049658 Polypeptide with cell-spreading activity |
09/17/1991 | US5049655 Melanin-concentrating hormones |
09/17/1991 | US5049654 Calcitonin gene related peptide derivatives |
09/17/1991 | US5049553 Angiotensin converting enzyme inhibitor |
09/17/1991 | US5049552 Compositions containing hexadecylphosphocholine and use thereof |
09/17/1991 | US5049548 Hypotensives |
09/17/1991 | US5049547 Polypeptide hormone for tanning |
09/17/1991 | US5049546 Fungicides |
09/17/1991 | US5049545 Insulin derivatives, a process for their preparation, and their use |
09/17/1991 | US5049392 Osmotically dependent vesicles |
09/17/1991 | US5049391 Liposome encapsulated hemoglobin |
09/17/1991 | US5049378 Prevention and treatment of porcine haemophilus pneumonia (PHP) |
09/17/1991 | CA1289092C Thermostable human cu/zn superoxide dismutase muteins |
09/17/1991 | CA1289072C Scaled-up production of liposome-encapsulated hemoglobin |
09/17/1991 | CA1289071C Pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient |
09/16/1991 | WO1991013909A1 Synthetic polypeptides |
09/16/1991 | WO1991013601A1 Calcitonin suppository formulations |
09/16/1991 | CA2078220A1 Synthetic polypeptides |
09/16/1991 | CA2078133A1 Calcitonin suppository formulations |
09/15/1991 | CA2038208A1 Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology |
09/14/1991 | CA2037990A1 Amino acid derivatives |
09/13/1991 | CA2037957A1 N-acylated cyclohexapeptide compounds |
09/13/1991 | CA2037821A1 Amyloid peptide precursor rna |
09/13/1991 | CA2036486A1 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
09/11/1991 | EP0446071A2 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis |
09/11/1991 | EP0446017A1 New diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
09/11/1991 | EP0445971A1 DNA encoding a major mite allergen and the use thereof |
09/11/1991 | EP0445894A2 Use of tumor necrosis factor |
09/11/1991 | EP0445796A2 Derivatives of acetic acid |
09/11/1991 | EP0445681A2 Preparation of a thrombin-binding substance |
09/11/1991 | EP0445625A1 Human monoclonal antibody against rabies virus, its production and use |
09/11/1991 | EP0445606A1 Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
09/11/1991 | EP0445581A1 Stable immunostimulating preparation for parenteral application, preparation and use thereof |
09/11/1991 | EP0445467A1 Renin inhibitors and antiviral agents |